Hunter C. Smith
2021
In 2021, Hunter C. Smith earned a total compensation of $2.3M as Chief Financial Officer at RHYTHM PHARMACEUTICALS, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $210,654 |
|---|---|
| Option Awards | $1,074,938 |
| Salary | $435,957 |
| Stock Awards | $576,264 |
| Other | $11,600 |
| Total | $2,309,412 |
Smith received $1.1M in option awards, accounting for 47% of the total pay in 2021.
Smith also received $210.7K in non-equity incentive plan, $436K in salary, $576.3K in stock awards and $11.6K in other compensation.
Rankings
In 2021, Hunter C. Smith's compensation ranked 5,470th out of 12,415 executives tracked by ExecPay. In other words, Smith earned more than 55.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,470 out of 12,415 | 56th |
Division Manufacturing | 2,311 out of 5,505 | 58th |
Major group Chemicals And Allied Products | 1,005 out of 2,375 | 58th |
Industry group Drugs | 895 out of 2,096 | 57th |
Industry Pharmaceutical Preparations | 644 out of 1,546 | 58th |
Source: SEC filing on April 27, 2023.
Smith's colleagues
We found four more compensation records of executives who worked with Hunter C. Smith at RHYTHM PHARMACEUTICALS in 2021.
2021
David Meeker
RHYTHM PHARMACEUTICALS
Chief Executive Officer
2021
Yann Mazabraud
RHYTHM PHARMACEUTICALS
Executive Vice President, Head of International
2021
Jennifer Chien
RHYTHM PHARMACEUTICALS
Executive Vice President, Head of North America
2021
Joseph Shulman
RHYTHM PHARMACEUTICALS